미션

In September 2020, the National Cancer Center launched the Asia Clinical Trials Network for Cancers Project (ATLAS project) with support from the government and AMED.

The mission of the ATLAS project is to formulate a multinational cancer clinical trial network, a solid structure for conducting international collaborative trials on a permanent basis in the Asian region.
The National Cancer Center has been conducting international trials in Asia, mainly with partners in Korea, Taiwan, China, and Singapore.

The ATLAS project is strengthening the existing network and expanding it to several Asian countries, including Thailand, Malaysia, Vietnam, Philippines, and Indonesia, to further develop cancer treatments. The new framework for conducting international joint trials hasing the type of cancer among Asian countries. 

Asian countries have extremely high potential as drug development areas in the future due to factors such as a large number of cancer patients, reasonable clinical trial costs, and an increase in the number of medical institutions equipped with high-quality clinical trial implementation Asian Partnerships Office in Bangkok, Thailand, located at the center of East and Southeast Asia. This office plays a key role in strengthening our network, with closer communication with our Asian partners.

The ATLAS project consists of three components: Institute development, international clinical research, and education. Nine partner sites from Asia have been selected, in which clinical trial facilities are being reinforced with purchased equipment, and hiring of specialist staff.

Several international collaborative trials are ongoing concurrently, in which partner institutes are participating. An investigator-initiated trial aimed at obtaining regulatory approval in participating countries, a clinical trial for spreading a new software as a medical device, translational studies collecting tumor tissue conducted, including early drug development research for cancer.

Researchers at ATLAS-related facilities are being trained in clinical trials, to build specialist institutes. Our collection of English language content on genomic medicine and clinical trials on “ICRweb,” an e-learning site hosted by the National Cancer Center has be y seminars and on-site capacity-building programs, inviting young investigators from Asian countries.

Cancer therapy development has primarily been led by the West. The ATLAS project aims to develop and firmly establish a clinical trial network in the Asian region, we are increasing Asia's presence as a third-tier region alongside the United States and Europe to produce even